Neonatal jaundice. Neonatal jaundice due to other excessive hemolysis
Conditions
Interventions
Intervention 1: Intervention group: Fenofibrate is given as a single dose of 10 mg per kg. Intervention 2: Control group: No medicine is given.
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 28 Days
Inclusion criteria
Inclusion criteria: Term neonatal (37 weeks to 41 weeks and 6 days) Neonatal with blood type A or B from mothers with positive O blood type and fathers with A, B or AB blood types Without congenital anomalies, birth trauma and history of resuscitation at birth Neonatal born by elective cesarean section who did not receive induction before delivery Rh incompatibility
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transcutaneous bilirubin level. Timepoint: Measurement of transcutaneous bilirubin levels at the end of 12, 24, 48 and 72 hours after birth and at the time of admission, in both control and fenofibrate groups. Method of measurement: Transcutaneous bilirubin meter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Jaundice leading to hospitalization. Timepoint: During hospitalization. Method of measurement: Blood test.;Duration of phototherapy. Timepoint: During hospitalization. Method of measurement: Duration in days.;The rate of severe jaundice. Timepoint: During hospitalization. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeddighe Norouzian
Babol University of Medical Sciences
Outcome results
None listed